Immunovant (IMVT) logo

Immunovant (IMVT) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -6

6 insiders sold $12.5M. No buys.

SellTiago Girao$188KChief Financial Officerat $28.50 on Oct 28, filed Oct 30
SellJay S. Stout$75KChief Technology Officerat $28.94 on Oct 21, filed Oct 23
SellMelanie Gloria$72KChief Operating Officerat $32.06 on Oct 7, filed Oct 9

From SEC Form 4s, the newest filed Oct 30, 2026 · Insiders have 2 business days to file a trade

30 more filings on IMVT in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 33 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on IMVT with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Immunovant

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about IMVT's insider trades

As of Nov 2, 2026: Immunovant (IMVT) has 33 insider filings on record in the last 6 months, the newest filed Oct 30, 2026. Its Quality Score is -6 (Poor). Scores as of 10:25 PM ET, 15 minutes behind.

Are IMVT insiders buying or selling?

6 insiders sold $12.5M across 33 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Tiago Girao, Chief Financial Officer, sold $188K on Oct 28, 2026.

Who are IMVT's biggest insider sellers?

By the dollars of their sales in the last 6 months: Andrew J. Fromkin (Director), 2 sales; Jay S. Stout (Chief Technology Officer), 10 sales; Melanie Gloria (Chief Operating Officer), 9 sales. 6 insiders sold in all.

When did an IMVT insider last buy?

No IMVT insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Tiago Girao on Oct 28, 2026.

Immunovant's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.